Skip to main content
Signal8

Rollins John Woodson

SEC insider (Form 3/4/5 filer). CIK 0002112941. Director at 20/20 Biolabs, Inc. (AIDX). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 19, 2026. Located in GAITHERSBURG, MD.

Companies Rollins John Woodson has filed insider reports for

  • 20/20 Biolabs, Inc. (AIDX): Director
Rollins John Woodson profile photo

Rollins John Woodson

CIK: 0002112941

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)0 (0.0%)

Compensation grants

Other (G, F, J, C, D, …)2 (100.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

20/20 Biolabs, Inc. logo
AIDX

20/20 Biolabs, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • 20/20 Biolabs, Inc. logo
    AIDX

    20/20 Biolabs, Inc.

    Feb 19, 2026
    Conversion
    Direct
    13K shares-
  • 20/20 Biolabs, Inc. logo
    AIDX

    20/20 Biolabs, Inc.

    Feb 19, 2026
    Conversion
    Direct
    6.1K shares-

1-2 of 2